Long-Term Monitoring and Daily Care
At a Glance
Children with ITCH deficiency need individualized long-term monitoring for lung, liver, intestinal, hormone, growth, and developmental problems. Infection prevention, vaccine guidance, written sick-day plans, and coordinated specialist care help families detect complications early.
Living with ITCH deficiency is a marathon, not a sprint. Because this condition can affect almost any part of the body, daily life often centers on a rigorous schedule of monitoring and prevention. While your child’s medical team will tailor a plan to their specific needs, management for Primary Immune Regulatory Disorders (PIRD) follows a multidisciplinary framework designed to protect the lungs, liver, and overall growth [1][2]. There is no universally established ITCH-specific surveillance schedule.
Multisystem Surveillance: Watching the “Quiet” Organs
In ITCH deficiency, inflammation can simmer beneath the surface before causing obvious symptoms. Regular screening is the best way to catch organ damage early.
- Pulmonary (Lung) Health: Damage to the lungs, such as bronchiectasis (permanent widening and scarring of the airways), is a significant risk [3][4].
- Monitoring: When age-appropriate, your child may need pulmonary function tests (PFTs) to measure how much air they can hold and how quickly they can exhale [5]. High-resolution chest CT scans can detect early scarring, but they are ordered carefully when the clinical benefit outweighs the risk of radiation exposure [6][7].
- Daily Care: If your child has documented bronchiectasis or mucus retention, a respiratory therapist may teach you airway clearance—techniques like chest physiotherapy or using a vibrating vest—to help them clear mucus and prevent infections [8].
- Liver and Gastrointestinal Health: Autoimmune hepatitis and gut inflammation (enteropathy) can lead to sudden complications [4][9].
- Endocrine and Growth: The immune system can attack hormone-producing glands at any time.
Preventing Infections
Children with ITCH deficiency face a “double whammy”: their natural immune defenses are altered (especially NK cells and CD8+ T-cells), and the medications used to treat them further weaken the immune system [2][13].
- Individualized Prophylaxis: Depending on your child’s specific immune function, infection history, and current immunosuppression, the team may prescribe individualized prophylactic antibiotics or antifungals, or IVIG (Intravenous Immunoglobulin) infusions [14][13]. These are not necessary for every child, carry risks like drug toxicity or antibiotic resistance, and should only be started or stopped under strict immunology guidance.
- Vaccination Safety: Live vaccines (like MMR or the chickenpox vaccine) can be dangerous for immunocompromised children and are often avoided [15]. Inactivated vaccines are generally safer but may be less effective. Your immunologist must approve all vaccines and provide guidance on precautions for household members receiving live vaccines.
- Household Precautions: Implement individualized infection-reduction measures such as staying away from people who are acutely ill, meticulous hand hygiene, and ventilation or masking when advised [16][17].
Managing the Daily Burden
The day-to-day management of ITCH deficiency can be taxing for both the child and the caregivers.
- Sick-Day Plans: Work with your team to create a written emergency sick-day plan with specific fever thresholds and a list of symptoms that require emergency services.
- Skin and Joint Care: If your child has psoriasis, daily application of medicated creams may be necessary to prevent painful cracking and secondary infections [9]. For arthritis, physical therapy and gentle movement can help maintain joint flexibility [9][8].
- Caregiver Support: Ask a social worker about school accommodation letters, home nursing, financial navigation, and respite care. Because some children experience global developmental delay, early intervention services (like speech or occupational therapy) can be critical for helping them reach their full potential [2][12].
By staying ahead of symptoms through strict monitoring and infection prevention, you are giving your child the best chance to remain stable while your medical team evaluates long-term options like transplant.
Common questions in this guide
How often should my child have lung tests for ITCH deficiency?
Are live vaccines safe for a child with ITCH deficiency?
What can we do at home to reduce infection risk?
What should a sick-day plan for my child include?
How is liver or intestinal inflammation monitored in ITCH deficiency?
How can we monitor growth and development at home?
What is airway clearance, and when might my child need it?
Get notified when new evidence is published on Syndromic multisystem autoimmune disease due to Itch deficiency.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.
References
References (17)
- 1
Primary Immune Regulatory Disorders (PIRD): Tools for Diagnosis and Disease Activity Assessment to Guide Therapy.
Oved JH, Torgerson TR, Chan AY
The journal of allergy and clinical immunology. In practice 2026; (14(7)):1467-1474 doi:10.1016/j.jaip.2026.05.015.
PMID: 42409454 - 2
ITCH Deficiency Causing Immunodeficiency and Immune Dysregulation.
Hernández A, Cerda C, María Vinet A, et al.
Pediatrics 2025; (156(5)) doi:10.1542/peds.2024-069311.
PMID: 41130596 - 3
Evaluation of respiratory complications in patients with X-linked and autosomal recessive agammaglobulinemia.
Fekrvand S, Yazdani R, Olbrich P, et al.
Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology 2020; (31(4)):405-417 doi:10.1111/pai.13228.
PMID: 32058651 - 4
Case Report: Sustained immune and pulmonary recovery three years after hematopoietic stem cell transplantation for ITCH E3 ubiquitin ligase deficiency.
Ashe B, Neal E, Kurland G, et al.
Frontiers in immunology 2026; (17()):1805196 doi:10.3389/fimmu.2026.1805196.
PMID: 42148098 - 5
Primary immunodeficiency diseases in lung disease: warning signs, diagnosis and management.
Soler-Palacín P, de Gracia J, González-Granado LI, et al.
Respiratory research 2018; (19(1)):219 doi:10.1186/s12931-018-0923-8.
PMID: 30419907 - 6
Pulmonary manifestations of immune dysregulation in CTLA-4 haploinsufficiency and LRBA deficiency.
Krone KA, Winant AJ, Vargas SO, et al.
Pediatric pulmonology 2021; (56(7)):2232-2241 doi:10.1002/ppul.25373.
PMID: 33710794 - 7
Radiological Patterns of Pediatric Non-cystic Fibrosis Bronchiectasis: A Retrospective Study From Oman.
Al Jabri M, Al Humaimi O, Al Yousufi F, et al.
Cureus 2025; (17(6)):e86516 doi:10.7759/cureus.86516.
PMID: 40698238 - 8
Pulmonary Rehabilitation in Inborn Errors of Immunity with Bronchiectasis: A Narrative Review with Implications for High-Consanguinity Settings.
Alruwaili R, Albelasi A, Alqahtani MM
Journal of clinical medicine 2026; (15(20)) doi:10.3390/jcm15208131.
PMID: 42941650 - 9
Immune Dysregulation in Human ITCH Deficiency Successfully Treated with Hematopoietic Cell Transplantation.
Patel T, Henrickson SE, Moser EK, et al.
The journal of allergy and clinical immunology. In practice 2021; (9(7)):2885-2893.e3 doi:10.1016/j.jaip.2021.04.010.
PMID: 33894394 - 10
Mutation in ITCH Gene Can Cause Syndromic Multisystem Autoimmune Disease With Acute Liver Failure.
Kleine-Eggebrecht N, Staufner C, Kathemann S, et al.
Pediatrics 2019; (143(2)) doi:10.1542/peds.2018-1554.
PMID: 30705142 - 11
Very Early Onset Inflammatory Bowel Disease: A Clinical Approach With a Focus on the Role of Genetics and Underlying Immune Deficiencies.
Ouahed J, Spencer E, Kotlarz D, et al.
Inflammatory bowel diseases 2020; (26(6)):820-842 doi:10.1093/ibd/izz259.
PMID: 31833544 - 12
ITCH deficiency clinical phenotype expansion and mitochondrial dysfunction.
Wolfe R, Heiman P, D'Annibale O, et al.
Molecular genetics and metabolism reports 2022; (33()):100932 doi:10.1016/j.ymgmr.2022.100932.
PMID: 36338154 - 13
Immunosuppression in Patients With Primary Immunodeficiency-Walking the Line.
Mustafa SS, Rider NL, Jolles S
The journal of allergy and clinical immunology. In practice 2022; (10(12)):3088-3096 doi:10.1016/j.jaip.2022.08.025.
PMID: 36049628 - 14
Inborn errors of immunity and invasive fungal infections: presentation and management.
Paccoud O, Warris A, Puel A, Lanternier F
Current opinion in infectious diseases 2024; (37(6)):464-473 doi:10.1097/QCO.0000000000001062.
PMID: 39259685 - 15
Vaccination in Primary Immunodeficiency Disorders.
Sobh A, Bonilla FA
The journal of allergy and clinical immunology. In practice 2016; (4(6)):1066-1075 doi:10.1016/j.jaip.2016.09.012.
PMID: 27836056 - 16
Infections in Disorders of Immune Regulation.
Thangaraj A, Tyagi R, Suri D, Gupta S
Pathogens (Basel, Switzerland) 2024; (13(3)) doi:10.3390/pathogens13030259.
PMID: 38535602 - 17
Insights From Early Clinical Trials Assessing Response to mRNA SARS-CoV-2 Vaccination in Immunocompromised Patients.
Baron F, Canti L, Ariën KK, et al.
Frontiers in immunology 2022; (13()):827242 doi:10.3389/fimmu.2022.827242.
PMID: 35309332
This page provides general information about long-term monitoring and daily care for a child with ITCH deficiency for informational purposes only and does not constitute medical advice. Your child's immunology team should guide testing, vaccines, medicines, and emergency decisions.